Literature DB >> 17051235

Microalbuminuria and early endothelial activation in essential hypertension.

S Cottone1, G Mulè, E Nardi, M C Lorito, M Guarneri, R Arsena, C Briolotta, A Vadalà, G Cerasola.   

Abstract

We hypothesized that in essential hypertensive patients (EHs), plasma levels of pro-atherogenic adhesion molecules would be increased and related with urine albumin excretion (UAE). Thus, this study was aimed at evaluating biochemical markers of endothelial activation and their relationship with UAE in a group of patients with uncomplicated EH. In basal condition soluble forms of adhesion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1, as well as 24-h UAE were assayed. One hundred patients with essential hypertension and no diabetes or ultrasonographic evidence of atherosclerosis were included in the study. Seventy normotensive healthy subjects served as controls. EHs were first studied overall, than were divided into two subgroups: those with UAE > or =20 mcg/min MAUs and those with UAE <20 mcg/min (non-MAUs). ICAM-1 (P<0.001) and VCAM-1 (P<0.0001) plasma concentrations were higher in EHs than in controls. Microalbuminuric EHs had greater levels of adhesion molecules than non-MAUs (ICAM-1 P=0.04; VCAM-1 P=0.02, respectively). In EHs UAE was correlated with ICAM-1 (r=0.29, P=0.003), and VCAM-1 (r=0.30, P=0.002). These associations were confirmed in multiple regression models (P=0.02 for both ICAM-1 and VCAM-1) including, along with adhesion molecules, age, body mass index and blood pressures. Our findings show that in essential hypertension there is a very early activation of endothelial adhesion molecules favouring atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051235     DOI: 10.1038/sj.jhh.1002109

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study.

Authors:  Jeanie B Tryggestad; Rachana D Shah; Barbara H Braffett; Fida Bacha; Samuel S Gidding; Rose A Gubitosi-Klug; Amy S Shah; Elaine M Urbina; Lorraine E Levitt Katz
Journal:  Pediatr Diabetes       Date:  2020-07-02       Impact factor: 4.866

2.  Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension.

Authors:  G Mulè; I Calcaterra; M Costanzo; M Morreale; F D'Ignoto; A Castiglia; G Geraci; G Rabbiolo; F Vaccaro; S Cottone
Journal:  J Hum Hypertens       Date:  2015-06-18       Impact factor: 3.012

Review 3.  Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.

Authors:  Rigas Kalaitzidis; George Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

4.  Association of systolic blood pressure and pulse pressure with microalbuminuria in treatment-naïve hypertensive patients.

Authors:  Nianjin Xie; Xida Li; Qi Zhong; Dan Zhou; Anping Cai; Ying Zhang; Yingling Zhou; Yingqing Feng
Journal:  Arch Med Sci       Date:  2018-08-23       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.